Abstract:
Objective To explore the safety and efficacy of domestic 2 μm Thulium laser vaporization for the patients with high risk recurrent benign prostatic hyperplasia (BPH).
Methods Clinical data of 23 patients with high risk recurrent BPH were analyzed retrospectively. The clinical factors including blood sodium and hemoglobin before and after operation, IPSS, QOL, Qmax, PVR, number of nocturia between the preoperation and 3-month, 6-month, 12-month postoperation were compared. Operative time, urinary canal indwelling time, duration of hospitalization and complications were recorded and evaluated for all patients.
Results Operative time ranged from 60 to 165min, the average time was (104±30) min. Indwelling catheter time ranged from 3 to 5 d, the average time was (3.0±0.8) d. Duration of hospitalzation was 4-7 d, the average time was (4.0±1.5) d. Preoperative and postoperative blood sodium and hemoglobin had no significant difference (P>0.05). Differences between preoperation and 3-month, 6-month, 12-month postoperation in IPSS, QOL, Qmax, PVR, number of nocturia weren't significant. But no differences were found between 3-month, 6-month, 12-month postoperation (P>0.05).
Conclusions The domestic 2 μm Thulium laser vaporization is a feasible, effective and safe method for treatment of high risk recurrent BPH and may have a promising future.
Key words:
Benign prostatic hyperplasia,
Domestic 2 μm Thulium laser,
High risk,
Recurrent
Liyang Gu, Xiaolong Liu, Yuxi Shan, Boxin Xue, Dongrong Yang, Chuanyang Sun. Domestic 2 μm Thulium laser vaporization for the patients with high risk recurrent benign prostatic hyperplasia[J]. Chinese Journal of Endourology(Electronic Edition), 2017, 11(06): 419-422.